Searched for
AMGEN INC.
ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...- Amgen expands global capability centre in Hyderabad with 500,000 sq ft leaseAmgen leases 500,000 sq ft in Hyderabad to establish its first global capability centre, enhancing its office space in the city. The new ce...
- Wall Street closes lower after Home Depot outlook, US retail salesDisappointing forecasts from Home Depot and soft April US retail sales data led to US stock indexes closing lower on Tuesday, with sentimen...
- Nvidia turns to AI cloud rental to spread new technologyThe Santa Clara, California-based company already dominates the field for artificial intelligence chips and has helped partners like Micros...
- Wall St dips as Fed decision looms; AMD boosts chipmakersAt 10:26 a.m. ET, the Dow Jones Industrial Average was down 219.55 points, or 0.64%, at 33,866.49, the S&P 500 was down 10.80 points, or 0....
- S&P 500, Nasdaq fall on fears of profit hit from inflation, rate hikesAt 12:11 p.m. ET, the Dow Jones Industrial Average was up 191.08 points, or 0.65%, at 29,393.96, the S&P 500 was down 2.75 points, or 0.08%...
- Alembic gets USFDA nod to market generic drugThe company has received tentative approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) ...
- Glenmark Pharma gets USFDA nod for erectile dysfunction treatmentGlenmark Pharmaceuticals Ltd has received final approval from the United States Food and Drug Administration (USFDA) for Tadalafil tablets ...
- S&P 500 ends lower as new COVID storm clouds overshadow stimulus passage"Today the market is catching its breath," said Ryan Detrick, senior market strategist at LPL Financial in Charlotte, North Carolina. "It's...
- S&P 500, Nasdaq close at record highs on trade, vaccine developmentsApple Inc weighed heaviest on all three indexes, its stock retreating 0.8% days ahead of its 4-to-1 stock split.
- S&P 500, Nasdaq close at record highs on trade, vaccine developmentsThat split, which will reduce Apple's weight in the Dow, prompted a reshuffle in the blue-chip industrial average, with Salesforce.com repl...
- Cipla settles case with Amgen Inc involving generic cinacalcet hydrochloride tabletsA formal stipulation of dismissal has been filed with the court and is awaiting signature by the presiding Judge, the filing added.
- Departing PepsiCo scientist to become CEO of anti-ageing startupLife Biosciences, with 103 employees, is trying to extend healthy lifespan by treating multiple diseases of ageing simultaneously.
- Big pharma returning to US price hikes in January after pausePfizer has already announced plans to hike prices on 41 of its drugs in mid-January.
- $42 billion asset manager fears bubble in world's biggest stocks“I’m a bit worried about the valuation of these very popular companies,” Robert Naess said.
- Neupogen, first drug to treat radiation sickness gets USFDA nodThe drug, Neupogen received approval by the US Food and Drug Administration (FDA) for the treatment of acute radiation injury.
- Indian American Vandana Slatter to run for city council in USVandana Slatter, an Indian- American clinical pharmacist has announced her candidacy for a city council seat in the US state of Washington.
- Japan's Takeda in $8.8 billion bid for US biotech firmJapan's Takeda Pharmaceutical Co has agreed to pay about $8.8 billion for US biotech company Millennium Pharmaceuticals Inc, the two firms ...
- Dr Reddy's developing 8 more biotech drugsDr. Reddy's Laboratories developing eight generic medicines using biotechnology.
- New data backs UCB drug for arthritisNew clinical data endorses the efficacy of UCB SA's experimental drug Cimzia given either fortnightly or monthly, researchers said on Thurs...
Load More
